CATEGORIES

India sets up Academic Chair in Ayurvedic Science at Western Sydney University
BioSpectrum Asia

India sets up Academic Chair in Ayurvedic Science at Western Sydney University

The Ministry of Ayush, Government of India, has formally announced the setting up of an Ayurveda Academic Chair based at Western Sydney University’s NICM Health Research Institute, with tenure for a period of three years.

time-read
1 min  |
December 2022
Mahidol University adopts virtual reality for medical education
BioSpectrum Asia

Mahidol University adopts virtual reality for medical education

Japan-based Jolly Good Inc., in collaboration with Juntendo University, will commence a demonstration project for the introduction of medical education with virtual reality (VR) for the purpose of developing medical human resources through the use of VR at Royal Mahidol University and throughout Thailand.

time-read
1 min  |
December 2022
Rounding up Digital Health Advancements across APAC in 2022
BioSpectrum Asia

Rounding up Digital Health Advancements across APAC in 2022

Over the past two years, Digital Health has been propelled into a realm of new care to create better efficiency, patient experience, while improving patient outcomes.

time-read
4 mins  |
December 2022
Healthcare Consumerisation Driving the Demand for Home Diagnostic Innovations in Asia
BioSpectrum Asia

Healthcare Consumerisation Driving the Demand for Home Diagnostic Innovations in Asia

The healthcare industry is witnessing a major shift in patient behaviour-- patients are more independent and aware of their health and well-being.

time-read
5 mins  |
December 2022
"There are many diseases for which mRNA approaches will be life-saving, including cancers"
BioSpectrum Asia

"There are many diseases for which mRNA approaches will be life-saving, including cancers"

What are your views on the current application and future perspectives of CRISPR/Cas9 mediated gene editing technology in developing new disease treatments? CRISPR/Caso9 gene editing is very powerful, but, not yet, as highly accurate as one would like.

time-read
2 mins  |
December 2022
A Powerful Performance
BioSpectrum Asia

A Powerful Performance

Allplex SARS-CoV-2 Assay by Seegene Inc

time-read
1 min  |
December 2022
Powering it with RNA
BioSpectrum Asia

Powering it with RNA

Aspin off from Agency of Science, Technology and Research A*STAR), Singapore-based startup MiRXES has commercialised its technology and eveloped accurate multi-cancer early detection solutions and made them readily available and accessible to people who need them.

time-read
1 min  |
December 2022
Revolutionising Healthcare with New-age Tech
BioSpectrum Asia

Revolutionising Healthcare with New-age Tech

Brain Navi Biotechnology, founded in 2015, is located in Hsinchu Biomedical Science Park in Taiwan.

time-read
1 min  |
December 2022
Accelerating Drug Discovery
BioSpectrum Asia

Accelerating Drug Discovery

Hummingbird Bioscience, founded in 2015, is an innovative clinical-stage biotech startup focused on developing precision therapies against hard-to drug targets to improve treatment outcomes.

time-read
1 min  |
December 2022
Lunit Lunit Inc Conquering Cancer With Al
BioSpectrum Asia

Lunit Lunit Inc Conquering Cancer With Al

South Korea-based Lunit Inc is a public company that develops medical artificial intelligence (AI) software that helps conquer cancer.

time-read
1 min  |
December 2022
Far-reaching Impact
BioSpectrum Asia

Far-reaching Impact

Dr Parul Ganju, a PhD in skin biology, from National Institute of Immunology (NII), New Delhi cofounded Ahammune Biosciences in 2016 in Pune, with Dr Krishnamurthy Natarajan, Professor, Jawaharlal Nehru University (JNU), New Delhi.

time-read
1 min  |
December 2022
Applying Deep Learning Experience to Drug Discovery
BioSpectrum Asia

Applying Deep Learning Experience to Drug Discovery

A leader in next-generation artificial intelligence (AI) technologies for drug discovery and biomarker development, Alex Zhavoronkov, PhD, is the founder and Chief Executive Officer of Hong Kong headquartered startup Insilico Medicine.

time-read
1 min  |
December 2022
An International Leader in Vaccinology
BioSpectrum Asia

An International Leader in Vaccinology

With an extensive background in child health and immunisation research, Professor Helen Marshall is best known for leading the world’s biggest study on meningococcal B disease.

time-read
4 mins  |
December 2022
BioSpectrum Asia Honours Industry Stalwarts
BioSpectrum Asia

BioSpectrum Asia Honours Industry Stalwarts

Asia has, indeed, become the new hub for potential growth and innovation, with no signs of losing steam.

time-read
5 mins  |
December 2022
Quadripartite launches new platform to tackle AMR threat to human, animal health
BioSpectrum Asia

Quadripartite launches new platform to tackle AMR threat to human, animal health

The Antimicrobial Resistance (AMR) Multi-Stakeholder Partnership Platform has been launched to ensure the growing threats and impacts of antimicrobial resistance are addressed globally.

time-read
1 min  |
December 2022
WHO inks new MoU on health workforce priorities
BioSpectrum Asia

WHO inks new MoU on health workforce priorities

The World Health Organisation (WHO) has signed a Memorandum of Understanding (MoU) with the five members of the World Health Professions Alliance (WHPA), World Dental Federation (FDI),

time-read
1 min  |
December 2022
WHO to identify pathogens likely to cause future outbreaks and pandemics
BioSpectrum Asia

WHO to identify pathogens likely to cause future outbreaks and pandemics

The World Health Organisation (WHO) is launching a global scientific process to update the list of priority pathogens, agents that can cause outbreaks or pandemics, to guide global investment, research and development (R&D), especially in vaccines, tests and treatments.

time-read
1 min  |
December 2022
Global health agencies support Uganda against outbreak of Ebolavirus disease
BioSpectrum Asia

Global health agencies support Uganda against outbreak of Ebolavirus disease

Following the declaration of an Ebola outbreak in Uganda on September 20, 2022, the outbreak has now spread to seven districts (Kasanda, Kyegegwa, Bunyangabu and Kagadi districts beyond the original epicentre in Mubende district, and then to Kampala City and Wakiso).

time-read
1 min  |
December 2022
Oral cholera vaccine receives manufacturing push for African & global markets
BioSpectrum Asia

Oral cholera vaccine receives manufacturing push for African & global markets

South Africa based biopharmaceutical company Biovac has concluded a ground-breaking licensing and technology transfer agreement with the International Vaccine Institute (IVI), a non-profit international organisation headquartered in South Korea, for the manufacture of an oral cholera vaccine (OCV).

time-read
1 min  |
December 2022
Tackling emerging antimalarial drug resistance in Africa
BioSpectrum Asia

Tackling emerging antimalarial drug resistance in Africa

The World Health Organisation (WHO) has launched a new strategy to respond to the urgent problem of antimalarial drug resistance in Africa.

time-read
1 min  |
December 2022
New Dutch Global Health Strategy calls for stronger cooperation
BioSpectrum Asia

New Dutch Global Health Strategy calls for stronger cooperation

The Netherlands discussed its new strategy for Global Health with the World Health Organisation (WHO) and called for deeper coordination with the organisation to improve global health – aiming to strengthen health systems at home and worldwide, better prepare for pandemics and address the impact of climate change on public health.

time-read
1 min  |
December 2022
Improved provision of mental health services to benefit Lithuanian youth
BioSpectrum Asia

Improved provision of mental health services to benefit Lithuanian youth

Strengthened governance and delivery of mental health services will improve the well-being of young people in Lithuania, according to a new World Bank report.

time-read
1 min  |
December 2022
Lunit accelerates AI-powered medical imaging across major overseas channels
BioSpectrum Asia

Lunit accelerates AI-powered medical imaging across major overseas channels

South Korea-based startup Lunit has signed a global distribution agreement with Indian firm CARPL.ai, an end-to-end healthcare technology platform that enables the development, validation, and deployment of artificial intelligence (AI) solutions across clinical workflows.

time-read
1 min  |
December 2022
Qmed Asia eyes APAC expansion with digital health solutions
BioSpectrum Asia

Qmed Asia eyes APAC expansion with digital health solutions

Malaysian startup Qmed Asia has announced regional expansion into Taiwan, Indonesia, Vietnam, and Cambodia to introduce value-added services to healthcare segments and patients in the form of innovative digital health solutions that are accessible, affordable, and reliable.

time-read
1 min  |
December 2022
RVAC Medicines, A*STAR to build capabilities for mRNA production in Singapore
BioSpectrum Asia

RVAC Medicines, A*STAR to build capabilities for mRNA production in Singapore

RVAC Medicines, a messenger RNA (mRNA) technology platform startup incubated by CBC Group, a healthcare-dedicated asset management firm headquartered in Singapore, and the Agency for Science, Technology and Research (A*STAR) have announced the signing of a master research collaboration agreement to jointly study and develop solutions to build mRNA manufacturing and analytics capabilities in Singapore.

time-read
1 min  |
December 2022
ANDHealth, LaunchVic launch Digital Health Accelerator in Australia
BioSpectrum Asia

ANDHealth, LaunchVic launch Digital Health Accelerator in Australia

ANDHealth, Australia’s leading digital health commercialisation organisation, has successfully secured $1.4 million in funding from LaunchVic to establish a novel accelerator programme for high growth potential digital health startups.

time-read
1 min  |
December 2022
MIRXES announces Southeast Asia's first business and clinical advisory programme
BioSpectrum Asia

MIRXES announces Southeast Asia's first business and clinical advisory programme

MiRXES, a Singapore-headquartered biotechnology startup focused on saving lives and improving health economics and outcomes through RNA-powered disease early detection and precision genomic tests, has launched the first edition of MiRXES Translator Programme,

time-read
1 min  |
December 2022
Medtronic launches Customer eXperience Center in Singapore
BioSpectrum Asia

Medtronic launches Customer eXperience Center in Singapore

Medtronic plc, a global leader in healthcare technology, has launched the Medtronic Customer eXperience Center (MCXC) in Singapore, leveraging innovative healthcare technologies across extended reality (XR), augmented and virtual realities, and robotics, to connect the global healthcare community from anywhere, at any time.

time-read
1 min  |
December 2022
QPS opens new preclinical research facility in Taiwan
BioSpectrum Asia

QPS opens new preclinical research facility in Taiwan

QPS, a global contract research organisation headquartered in the US, has opened a second preclinical research facility in Taipei, Taiwan.

time-read
1 min  |
December 2022
Boston Scientific expands operations in Malaysia
BioSpectrum Asia

Boston Scientific expands operations in Malaysia

Boston Scientific Corporation, a global leader in medical device technology, has unveiled a new expansion of its operations in Batu Kawan, Penang, Malaysia.

time-read
1 min  |
December 2022